Table 1.

Healthy controls and patients without T1R evaluated for circulating CXCL10 at a single time point (cross sectional) and/or at monthly intervals for 6 months

Cohorta	n	No. M/no. Fb	Age range (yr)	Leprosy type	Reaction	Notes
X	10	7/3	23–42	Healthy	NAc
X	6	5/1	19–55	LL	None
X	10	8/2	20–55	LL	T2R
X	10	8/2	15–50	BL	None
X, S	10	8/2	15–50	BL	T1R	7 patients in both X and S
X	10	6/4	20–50	BT	None
X, S	10	7/3	20–50	BT	T1R	9 patients in both X and S

^aX, cross sectional; S, 6-month intervals.

^bM, male; F, female.

^cNA, not applicable.